BioCryst Pharmaceuticals Inc. Public Market Comparables
Find the most relevant public market comparables for BioCryst Pharmaceuticals Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
BioCryst Pharmaceuticals Inc. is a biotechnology company that designs, optimizes, and develops small molecule drugs to block critical enzymes in the pathogenesis of diseases. The company focuses on the treatment of rare diseases and develops drugs for infectious diseases and hereditary angioedema.
Business Model
Research and development of novel small-molecule drugs targeting key enzymes involved in infectious and inflammatory diseases. Commercialization of approved drugs.
Target Customers
Patients with rare diseases, particularly hereditary angioedema (HAE), and those with influenza.
Specific Focus
Development of oral drugs for rare and serious diseases, with a focus on hereditary angioedema and antiviral therapies.
Location
Durham, North Carolina
CEO
Jon P. Stonehouse
Industry
Life sciences
Sub Sector
Pharmaceuticals
3yr Revenue Growth
1,761%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to BioCryst Pharmaceuticals Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for BioCryst Pharmaceuticals Inc.? Our platform provides detailed analysis of BioCryst Pharmaceuticals Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full BioCryst Pharmaceuticals Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full BioCryst Pharmaceuticals Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, BioCryst Pharmaceuticals Inc. operates in the specialized Pharmaceuticals sub-sector. Understanding how BioCryst Pharmaceuticals Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Pharmaceuticals space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Intra-Cellular Therapies, Inc.
Pharmaceuticals • Life sciences
A biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs that address underserved medical needs primarily in neuropsychiatric and neurological disorders. The company develops novel drugs for treating diseases of the central nervous system, leveraging proprietary chemistry platforms to develop drugs for neurodegenerative diseases.
Moderna
Biotechnology • Life sciences
Moderna is a biotechnology company specializing in messenger RNA (mRNA) therapeutics and vaccines. They develop and discover drugs that produce proteins or antibodies inside patient cells, focusing on areas such as infectious diseases, rare liver disease, immuno-oncology, and cardiovascular disease. Their mRNA platform produces human proteins, antibodies, and novel proteins to prevent, treat, and cure diseases.
Gyre Therapeutics, Inc.
Pharmaceuticals & Biotech • Life sciences
A commercial-stage biopharmaceutical company focused on the research, development, manufacturing, and commercialization of drugs for organ fibrosis. They develop and commercialize small-molecule anti-inflammatory and anti-fibrotic drugs targeting organ diseases, specifically organ fibrosis. The company has commercial-stage products and a diverse pipeline of drug candidates, operating in both the US and China.
Get Your Custom Comparable Analysis
Need a more detailed analysis of BioCryst Pharmaceuticals Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free